|
Section I Diagnostic Imaging |
|
|
1 | (138) |
|
A Abdominal and Gastrointestinal (GI) Imaging |
|
|
4 | (38) |
|
1 Abdominal Film, Plain (Kidney, Ureter, and Bladder [ KUB]) |
|
|
4 | (1) |
|
|
5 | (2) |
|
3 Barium Swallow (Esophagram) |
|
|
7 | (1) |
|
|
8 | (1) |
|
5 Computed Tomographic Colonography (CTC, Virtual Colonoscopy) |
|
|
9 | (1) |
|
6 CT Scan of Abdomen and Pelvis |
|
|
10 | (2) |
|
|
12 | (5) |
|
|
17 | (1) |
|
9 Magnetic Resonance Enterography (MRE) |
|
|
18 | (1) |
|
10 Cholescintigraphy (Hepatobiliary Iminodiacetic Acid [ HIDA] Scan, Diisopropyl Iminodiacetic Acid [ DISIDA] Scan) |
|
|
19 | (2) |
|
11 Endoscopic Retrograde Cholangiopancreatography (ERCP) |
|
|
21 | (1) |
|
12 Percutaneous Biliary Procedures |
|
|
22 | (1) |
|
13 Magnetic Resonance Cholangiopancreatography (MRCP) |
|
|
23 | (2) |
|
14 Meckel Scan (Tc-99m Pertechnetate Scintigraphy) |
|
|
25 | (1) |
|
15 MRI Scan of Abdomen/Pelvis |
|
|
26 | (2) |
|
|
28 | (1) |
|
17 Tc-99m Sulfur Colloid (Tc-99m SC) Scintigraphy for GI Bleeding |
|
|
29 | (1) |
|
18 Tc-99m-Labeled Red Blood Cell (RBC) Scintigraphy for GI Bleeding |
|
|
30 | (1) |
|
|
30 | (2) |
|
20 Ultrasound of Appendix |
|
|
32 | (1) |
|
21 Ultrasound of Gallbladder and Bile Ducts |
|
|
33 | (2) |
|
|
35 | (1) |
|
23 Ultrasound of Pancreas |
|
|
35 | (4) |
|
24 Endoscopic Ultrasound (EUS) |
|
|
39 | (1) |
|
25 Video Capsule Endoscopy (VCE) |
|
|
40 | (2) |
|
26 Transient Elastography (FibroScan) |
|
|
42 | (1) |
|
|
42 | (6) |
|
|
42 | (2) |
|
|
44 | (3) |
|
|
47 | (1) |
|
|
48 | (18) |
|
1 Stress Echocardiography |
|
|
48 | (2) |
|
2 Cardiovascular Radionuclide Imaging (Thallium, Sestamibi, Dipyridamole [ Persantine] Scan), Positron Emission Tomography (PET), Single-Photon Emission Computed Tomography (SPECT) |
|
|
50 | (1) |
|
|
51 | (4) |
|
4 Multidetector CT Scan (Non-contrast CT Scan for Coronary Artery Calcium Scoring) |
|
|
55 | (3) |
|
5 Transesophageal Echocardiogram (TEE) |
|
|
58 | (1) |
|
6 Transthoracic Echocardiography (TTE) |
|
|
59 | (1) |
|
7 Intravascular Ultrasound (IVUS) |
|
|
60 | (6) |
|
|
66 | (8) |
|
|
66 | (2) |
|
|
68 | (5) |
|
|
73 | (1) |
|
|
74 | (4) |
|
1 Adrenal Medullary Scintigraphy (Metaiodobenzylguanidine [ MIBG] Scan) |
|
|
74 | (1) |
|
|
75 | (1) |
|
3 Thyroid Scan (Radioiodine Uptake Study) |
|
|
76 | (1) |
|
|
77 | (1) |
|
|
78 | (10) |
|
|
78 | (1) |
|
|
78 | (2) |
|
|
80 | (1) |
|
|
81 | (1) |
|
|
82 | (1) |
|
6 Transvaginal (Endovaginal) Ultrasound |
|
|
83 | (1) |
|
7 Urinary Bladder Ultrasound |
|
|
84 | (1) |
|
8 Hysterosalpingography (HSG) |
|
|
85 | (1) |
|
9 Intravenous Pyelography (IVP) and Intravenous Retrograde Pyelography |
|
|
86 | (2) |
|
G Musculoskeletal and Spinal Cord Imaging |
|
|
88 | (14) |
|
1 Plain X-Ray Films of Skeletal System |
|
|
88 | (1) |
|
2 Bone Densitometry (Dual-Energy X-Ray Absorptiometry [ DEXA] Scan) |
|
|
89 | (1) |
|
|
90 | (3) |
|
|
93 | (1) |
|
5 MRI Scan of Hip and Extremities |
|
|
94 | (1) |
|
|
95 | (1) |
|
|
95 | (3) |
|
|
98 | (1) |
|
|
99 | (1) |
|
|
100 | (1) |
|
11 Nuclear Imaging (Bone Scan, Gallium Scan, White Blood Cell [ WBC] Scan) |
|
|
100 | (2) |
|
|
102 | (5) |
|
|
102 | (1) |
|
|
103 | (4) |
|
I Positron Emission Tomography (PET) |
|
|
107 | (2) |
|
J Single-Photon Emission Computed Tomography (SPECT) |
|
|
109 | (1) |
|
|
110 | (25) |
|
|
110 | (3) |
|
|
113 | (2) |
|
|
115 | (1) |
|
4 Captopril Renal Scan (CRS) |
|
|
115 | (1) |
|
5 Carotid Ultrasonography |
|
|
116 | (1) |
|
6 Computed Tomographic Angiography (CTA) |
|
|
117 | (2) |
|
7 Cardiac Computed Tomography Angiography |
|
|
119 | (1) |
|
8 Computed Tomography Perfusion (CTP) Imaging |
|
|
120 | (1) |
|
9 Cardiac Catheterization and Angiography |
|
|
121 | (1) |
|
10 Magnetic Resonance Angiography (MRA) |
|
|
121 | (8) |
|
11 Magnetic Resonance Direct Thrombus Imaging (MRDTI) |
|
|
129 | (1) |
|
|
129 | (1) |
|
|
130 | (1) |
|
|
131 | (1) |
|
15 Compression Ultrasonography and Venous Doppler Ultrasound |
|
|
132 | (1) |
|
16 Ventilation/Perfusion (V/Q) Lung Scan |
|
|
133 | (2) |
|
|
135 | (4) |
|
1 Whole-Body Integrated (Dual-Modality) PET-CT |
|
|
135 | (2) |
|
|
137 | (2) |
|
|
137 | (2) |
|
Section II Laboratory Values and Interpretation of Results |
|
|
139 | (114) |
|
|
148 | (1) |
|
Acetone (Serum or Plasma) |
|
|
148 | (1) |
|
Acetylcholine Receptor (AChR) Antibody |
|
|
148 | (1) |
|
|
148 | (1) |
|
|
148 | (1) |
|
Activated Clotting Time (ACT) |
|
|
148 | (1) |
|
Activated Partial Thromboplastin Time (aPTT) |
|
|
148 | (1) |
|
Adrenocorticotropic Hormone (ACTH) |
|
|
148 | (1) |
|
|
149 | (1) |
|
Alanine Aminotransferase (ALT, Formerly Serum Glutamic-Pyruvic Transaminase [ SGPT]) |
|
|
149 | (1) |
|
|
149 | (1) |
|
|
149 | (1) |
|
|
149 | (1) |
|
|
149 | (1) |
|
Alkaline Phosphatase (Serum) |
|
|
150 | (1) |
|
Alpha-1-Antitrypsin (Serum) |
|
|
151 | (1) |
|
Alpha-1-Fetoprotein (Serum) |
|
|
151 | (1) |
|
|
151 | (1) |
|
|
151 | (1) |
|
|
151 | (1) |
|
|
152 | (1) |
|
Aminolevulinic Acid (d-ALA) (24-Hour Urine Collection) |
|
|
152 | (1) |
|
|
152 | (1) |
|
|
152 | (1) |
|
|
152 | (1) |
|
Amyloid A Protein (Serum) |
|
|
152 | (1) |
|
|
152 | (1) |
|
Anaplasma Phagocytophilum (HGA) |
|
|
152 | (1) |
|
|
152 | (1) |
|
|
153 | (1) |
|
|
153 | (1) |
|
Angiotensin-Converting Enzyme (ACE) Level |
|
|
153 | (1) |
|
|
153 | (1) |
|
|
153 | (1) |
|
Anticardiolipin Antibody (ACA) |
|
|
153 | (1) |
|
|
153 | (1) |
|
|
154 | (1) |
|
|
154 | (1) |
|
|
154 | (1) |
|
|
155 | (1) |
|
Antiglobulin Test, Direct |
|
|
155 | (1) |
|
Antiglobulin Test, Indirect |
|
|
155 | (1) |
|
Antiglomerular Basement Antibody |
|
|
155 | (1) |
|
|
155 | (1) |
|
|
155 | (1) |
|
|
155 | (1) |
|
Antimitochondrial Antibody (AMA) |
|
|
155 | (1) |
|
Antineutrophil Cytoplasmic Antibody (ANCA) |
|
|
155 | (1) |
|
Antinuclear Antibody (ANA) |
|
|
155 | (1) |
|
Antiphospholipid Antibody |
|
|
156 | (1) |
|
|
156 | (1) |
|
|
156 | (1) |
|
Anti-Smith (Anti-Sm) Antibody |
|
|
157 | (1) |
|
Anti-Smooth Muscle Antibody |
|
|
157 | (1) |
|
Antistreptolysin O Titer (Streptozyme, ASLO Titer) |
|
|
157 | (1) |
|
|
157 | (1) |
|
Apolipoprotein A-1 (Apo A-1) |
|
|
157 | (1) |
|
|
157 | (1) |
|
|
157 | (3) |
|
|
160 | (1) |
|
|
160 | (1) |
|
Aspartate Aminotransferase (AST, Serum Glutamic Oxaloacetic Transaminase [ SGOT]) |
|
|
160 | (1) |
|
Atrial Natriuretic Hormone (ANH) |
|
|
161 | (1) |
|
|
161 | (1) |
|
|
161 | (1) |
|
|
161 | (1) |
|
|
161 | (1) |
|
|
161 | (1) |
|
Bilirubin, Direct (Conjugated Bilirubin) |
|
|
162 | (1) |
|
Bilirubin, Indirect (Unconjugated Bilirubin) |
|
|
162 | (1) |
|
|
162 | (1) |
|
|
162 | (1) |
|
Bladder Tumor-Associated Antigen |
|
|
162 | (1) |
|
Bleeding Time (Modified IVY Method) |
|
|
162 | (1) |
|
|
163 | (2) |
|
|
165 | (1) |
|
Bordetella pertussis Serology |
|
|
165 | (1) |
|
|
165 | (1) |
|
|
165 | (1) |
|
B-Type Natriuretic Peptide (BNP) |
|
|
165 | (1) |
|
|
166 | (1) |
|
|
166 | (1) |
|
|
166 | (1) |
|
|
166 | (1) |
|
|
166 | (1) |
|
|
166 | (1) |
|
|
166 | (1) |
|
|
166 | (1) |
|
|
166 | (1) |
|
|
166 | (1) |
|
|
167 | (1) |
|
Cancer Antigen 15-3 (CA 15-3) |
|
|
167 | (1) |
|
Cancer Antigen 19-9 (CA 19-9) |
|
|
167 | (1) |
|
Cancer Antigen 27-29 (CA 27-29) |
|
|
167 | (2) |
|
Cancer Antigen 72-4 (CA 72-4) |
|
|
169 | (1) |
|
Cancer Antigen 125 (CA-125) |
|
|
169 | (1) |
|
Captopril Stimulation Test |
|
|
169 | (1) |
|
|
169 | (1) |
|
Carbohydrate Antigen 19-9 |
|
|
169 | (1) |
|
Carbon Dioxide, Partial Pressure |
|
|
170 | (1) |
|
|
170 | (1) |
|
|
170 | (1) |
|
|
170 | (1) |
|
|
171 | (1) |
|
Carcinoembryonic Antigen (CEA) |
|
|
171 | (1) |
|
|
172 | (1) |
|
|
172 | (1) |
|
|
172 | (1) |
|
|
172 | (1) |
|
|
172 | (1) |
|
|
172 | (1) |
|
|
172 | (1) |
|
CD4 T-Lymphocyte Count (CD4 T-Cells) |
|
|
172 | (1) |
|
|
173 | (1) |
|
|
173 | (1) |
|
Cerebrospinal Fluid (CSF) |
|
|
173 | (3) |
|
|
176 | (1) |
|
Chlamydia Group Antibody Serologic Test |
|
|
176 | (1) |
|
Chlamydia trachomatis Nucleic Acid Amplification Test (NAAT) |
|
|
176 | (1) |
|
Chlamydia trachomatis Polymerase Chain Reaction (PCR) |
|
|
176 | (1) |
|
|
176 | (1) |
|
|
177 | (1) |
|
|
177 | (1) |
|
Cholecystokinin-Pancreozymin (CCK, CCK-PZ) |
|
|
177 | (1) |
|
Cholesterol, Low-Density Lipoprotein |
|
|
177 | (1) |
|
Cholesterol, High-Density Lipoprotein |
|
|
177 | (1) |
|
|
177 | (1) |
|
Chorionic Gonadotropin (hCG), Human (Serum) |
|
|
177 | (1) |
|
|
178 | (1) |
|
Circulating Anticoagulant (Antiphospholipid Antibody, Lupus Anticoagulant) |
|
|
178 | (1) |
|
|
178 | (1) |
|
Clonidine Suppression Test |
|
|
178 | (1) |
|
Clostridium (Clostridioides) difficile Toxin Assay (Stool) |
|
|
178 | (1) |
|
|
178 | (1) |
|
|
178 | (2) |
|
|
180 | (1) |
|
|
180 | (1) |
|
Complete Blood Cell (CBC) Count (Normal Values) |
|
|
181 | (1) |
|
|
182 | (1) |
|
|
182 | (1) |
|
Coombs, Indirect (Antiglobulin, Indirect) |
|
|
182 | (1) |
|
|
183 | (1) |
|
|
183 | (1) |
|
|
183 | (1) |
|
Corticotropin-Releasing Hormone (CRH) Stimulation Test |
|
|
183 | (1) |
|
|
183 | (1) |
|
|
183 | (1) |
|
|
184 | (1) |
|
|
184 | (1) |
|
|
184 | (1) |
|
|
184 | (1) |
|
Creatine Kinase (CK), Creatine Phosphokinase (CPK) |
|
|
185 | (1) |
|
Creatine Kinase Isoenzymes |
|
|
185 | (1) |
|
|
186 | (1) |
|
|
186 | (1) |
|
|
186 | (1) |
|
Cryptosporidium Antigen by Enzyme Immunoassay (EIA) (Stool) |
|
|
186 | (1) |
|
|
186 | (1) |
|
|
186 | (1) |
|
Cystic Fibrosis Polymerase Chain Reaction (PCR) |
|
|
187 | (1) |
|
Cytomegalovirus by Polymerase Chain Reaction (PCR) |
|
|
187 | (1) |
|
|
187 | (1) |
|
|
187 | (1) |
|
Dehydroepiandrosterone Sulfate |
|
|
187 | (1) |
|
Deoxycorticosterone (11-Deoxycorticosterone, DOC), Serum |
|
|
187 | (1) |
|
Dexamethasone Suppression Test, Overnight |
|
|
188 | (1) |
|
|
188 | (1) |
|
Dihydrotestosterone, Serum, Urine |
|
|
188 | (1) |
|
|
189 | (1) |
|
Direct Antiglobulin Test (DAT, Coombs Test Direct) |
|
|
189 | (1) |
|
Disaccharide Absorption Tests |
|
|
190 | (1) |
|
|
190 | (1) |
|
Donath-Landsteiner (D-L) Test for Paroxysmal Cold Hemoglobinuria |
|
|
190 | (1) |
|
|
190 | (1) |
|
|
190 | (1) |
|
|
190 | (1) |
|
Electrophoresis, Hemoglobin |
|
|
190 | (1) |
|
|
190 | (1) |
|
|
190 | (1) |
|
|
191 | (1) |
|
|
191 | (1) |
|
|
191 | (1) |
|
Epstein-Barr Virus (EBV) Serology |
|
|
191 | (1) |
|
Erythrocyte Sedimentation Rate (ESR) (Westergren) |
|
|
192 | (1) |
|
|
192 | (1) |
|
|
192 | (1) |
|
|
192 | (1) |
|
|
193 | (1) |
|
Extractable Nuclear Antigen (ENA Complex, Anti-RNP Antibody, Anti-SM, Anti-Smith) |
|
|
193 | (1) |
|
|
193 | (1) |
|
|
193 | (1) |
|
|
193 | (1) |
|
|
193 | (1) |
|
Fecal FAT, Quantitative (72-Hour Collection) |
|
|
193 | (1) |
|
Fecal Globin Immunochemical Test |
|
|
193 | (1) |
|
|
194 | (1) |
|
Fibrin Degradation Product (FDP) |
|
|
194 | (1) |
|
|
194 | (1) |
|
5-Hydroxyindole-Acetic Acid, Urine |
|
|
194 | (1) |
|
|
194 | (1) |
|
Fluorescent Treponemal Antibody |
|
|
194 | (1) |
|
|
194 | (1) |
|
Follicle-Stimulating Hormone (FSH) |
|
|
194 | (1) |
|
Fractional Excretion of Sodium (FENA) |
|
|
195 | (1) |
|
|
195 | (1) |
|
|
195 | (1) |
|
|
195 | (1) |
|
|
196 | (1) |
|
Furosemide Stimulation Test |
|
|
196 | (1) |
|
Gamma-Glutamyl Transferase 1 (GGT) |
|
|
196 | (1) |
|
|
196 | (1) |
|
|
196 | (1) |
|
Gliadin Antibodies, Immunoglobulin (Ig) AandlgG |
|
|
196 | (1) |
|
Glomerular Basement Membrane Antibody |
|
|
196 | (1) |
|
Glomerular Filtration Rate (GFR) |
|
|
196 | (1) |
|
|
197 | (1) |
|
|
198 | (1) |
|
|
198 | (1) |
|
|
198 | (1) |
|
Glucose-6-Phosphate Dehydrogenase (G6PD) Screen (Blood) |
|
|
198 | (1) |
|
γ-Glutamyl Transferase (GGT) |
|
|
198 | (1) |
|
Glycated (Glycosylated) Hemoglobin (HbAlc) |
|
|
198 | (1) |
|
|
199 | (1) |
|
|
199 | (1) |
|
Growth Hormone-Releasing Hormone (GHRH) |
|
|
199 | (1) |
|
Growth Hormone Suppression Test (After Glucose) |
|
|
199 | (1) |
|
Ham Test (Acid Serum Test) |
|
|
199 | (1) |
|
|
199 | (1) |
|
|
199 | (1) |
|
|
199 | (1) |
|
|
200 | (1) |
|
Helicobacter pylori (Serology, Stool Antigen) |
|
|
200 | (1) |
|
|
200 | (1) |
|
|
200 | (1) |
|
Hemoglobin (Hb) Electrophoresis |
|
|
201 | (1) |
|
|
201 | (1) |
|
|
201 | (1) |
|
|
202 | (1) |
|
|
202 | (1) |
|
|
202 | (1) |
|
Heparin-Induced Thrombocytopenia Antibodies |
|
|
202 | (1) |
|
|
203 | (1) |
|
Hepatitis B Core Antibody |
|
|
203 | (1) |
|
|
203 | (1) |
|
Hepatitis Be Antigen (HBeAg) and Antibody |
|
|
204 | (1) |
|
Hepatitis B Surface Antibody |
|
|
204 | (1) |
|
Hepatitis B Surface Antigen (HBsAg) |
|
|
204 | (1) |
|
Hepatitis C Antibody (Anti-HCV) |
|
|
204 | (1) |
|
|
204 | (1) |
|
|
205 | (1) |
|
Hepatitis D Antigen and Antibody |
|
|
205 | (1) |
|
|
206 | (1) |
|
Herpes Simplex Virus (HSV) |
|
|
206 | (1) |
|
|
206 | (1) |
|
HFE Screen for Hereditary Hemochromatosis |
|
|
207 | (1) |
|
High-Density Lipoprotein (HDL) Cholesterol |
|
|
207 | (1) |
|
|
207 | (1) |
|
|
208 | (1) |
|
|
208 | (1) |
|
Human Chorionic Gonadotropins (hCG) |
|
|
208 | (1) |
|
Human Herpes Virus 8 (HHV8) |
|
|
208 | (1) |
|
Human Immunodeficiency Virus Antibody, Type 1 (HIV-1) |
|
|
208 | (1) |
|
Human Papilloma Virus (HPV) |
|
|
209 | (1) |
|
Huntington Disease Polymerase Chain Reaction (PCR) |
|
|
209 | (1) |
|
|
210 | (1) |
|
|
210 | (1) |
|
|
210 | (1) |
|
|
211 | (1) |
|
|
211 | (1) |
|
|
211 | (1) |
|
|
211 | (1) |
|
Insulin-Like Growth Factor 1 (IGF-1), Serum |
|
|
211 | (1) |
|
Insulin-Like Growth Factor II |
|
|
212 | (1) |
|
International Normalized Ratio (INR) |
|
|
212 | (1) |
|
Intrinsic Factor Antibodies |
|
|
212 | (1) |
|
Iron-Binding Capacity (Total Iron-Binding Capacity 1TIBC]) |
|
|
212 | (1) |
|
Iron Saturation (% Transferrin Saturation) |
|
|
212 | (1) |
|
|
213 | (1) |
|
|
213 | (1) |
|
Lactate Dehydrogenase (LDH) |
|
|
213 | (1) |
|
Lactate Dehydrogenase (LDH) Isoenzymes |
|
|
213 | (1) |
|
Lactose Tolerance Test (Serum) |
|
|
213 | (1) |
|
|
213 | (1) |
|
|
214 | (1) |
|
|
214 | (1) |
|
|
214 | (1) |
|
Legionella pneumophila Polymerase Chain Reaction (PCR) |
|
|
214 | (1) |
|
|
215 | (1) |
|
Leukocyte Alkaline Phosphatase (LAP) |
|
|
215 | (1) |
|
|
215 | (1) |
|
|
215 | (1) |
|
|
215 | (1) |
|
Lipoprotein Cholesterol, Low Density |
|
|
215 | (1) |
|
Lipoprotein Cholesterol, High Density |
|
|
215 | (1) |
|
Liver Kidney Microsome Type 1 (LKM1) Antibodies |
|
|
215 | (1) |
|
Low-Density Lipoprotein (LDL) Cholesterol |
|
|
216 | (1) |
|
Lupus Anticoagulant (LA) Test |
|
|
216 | (1) |
|
Luteinizing Hormone (LH), Blood |
|
|
216 | (1) |
|
|
216 | (1) |
|
|
216 | (1) |
|
Mean Corpuscular Volume (MCV) |
|
|
217 | (1) |
|
|
217 | (1) |
|
Methylmalonic Acid, Serum |
|
|
217 | (1) |
|
Mitochondrial Antibody (Antimitochondrial Antibody [ AMA]) |
|
|
217 | (1) |
|
|
218 | (1) |
|
Mycoplasma pneumoniae Polymerase Chain Reaction (PCR) |
|
|
218 | (1) |
|
Myelin Basic Protein, Cerebrospinal Fluid |
|
|
218 | (1) |
|
|
218 | (1) |
|
|
218 | (1) |
|
Neisseria gonorrhoeae Nucleic Acid Amplification Test (NAAT) |
|
|
219 | (1) |
|
Neisseria gonorrhoeae Polymerase Chain Reaction (PCR) |
|
|
219 | (1) |
|
|
219 | (1) |
|
|
219 | (1) |
|
|
219 | (1) |
|
|
219 | (1) |
|
|
219 | (1) |
|
|
220 | (1) |
|
|
221 | (1) |
|
|
221 | (1) |
|
Partial Thromboplastin Time (PTT), Activated Partial Thromboplastin Time(aPTT) |
|
|
221 | (1) |
|
|
222 | (1) |
|
|
222 | (1) |
|
|
222 | (1) |
|
|
222 | (1) |
|
|
222 | (1) |
|
|
222 | (1) |
|
|
222 | (1) |
|
|
222 | (1) |
|
|
223 | (1) |
|
|
223 | (1) |
|
|
223 | (1) |
|
|
223 | (1) |
|
|
224 | (1) |
|
Platelet Function Analysis (PFA) 100 Assay |
|
|
224 | (1) |
|
|
225 | (1) |
|
|
226 | (1) |
|
|
226 | (1) |
|
|
226 | (1) |
|
Prostate-Specific Antigen (PSA) |
|
|
227 | (1) |
|
Prostatic Acid Phosphatase |
|
|
227 | (1) |
|
|
227 | (1) |
|
|
227 | (1) |
|
Protein Electrophoresis (Serum) |
|
|
227 | (2) |
|
|
229 | (1) |
|
|
229 | (1) |
|
Protoporphyrin (Free Erythrocyte) |
|
|
229 | (1) |
|
|
229 | (1) |
|
|
229 | (1) |
|
|
230 | (1) |
|
|
230 | (1) |
|
|
230 | (1) |
|
|
230 | (1) |
|
|
230 | (1) |
|
|
230 | (1) |
|
Red Blood Cell Distribution Width (RDW) |
|
|
231 | (1) |
|
|
231 | (1) |
|
Red Blood Cell Mass (Volume) |
|
|
231 | (1) |
|
|
231 | (1) |
|
Respiratory Syncytial Virus (RSV) Screen |
|
|
231 | (1) |
|
|
232 | (1) |
|
|
232 | (1) |
|
|
232 | (1) |
|
|
232 | (1) |
|
|
232 | (1) |
|
|
233 | (1) |
|
|
233 | (1) |
|
|
234 | (1) |
|
|
234 | (1) |
|
|
234 | (1) |
|
|
234 | (1) |
|
|
234 | (1) |
|
|
234 | (1) |
|
|
234 | (1) |
|
|
235 | (1) |
|
Sucrose Hemolysis Test (Sugar Water Test) |
|
|
235 | (1) |
|
Sudan III Stain (Qualitative Screening for Fecal Fat) |
|
|
236 | (1) |
|
|
236 | (1) |
|
|
236 | (1) |
|
T4, Serum T4, and Free (Free Thyroxine) |
|
|
236 | (1) |
|
|
236 | (1) |
|
|
237 | (1) |
|
|
237 | (1) |
|
|
237 | (1) |
|
|
237 | (1) |
|
|
238 | (1) |
|
|
238 | (1) |
|
|
238 | (1) |
|
Thyroid-Binding Globulin (TBG) |
|
|
239 | (1) |
|
Thyroid Microsomal Antibodies |
|
|
239 | (1) |
|
Thyroid-Stimulating Hormone (TSH) |
|
|
239 | (1) |
|
Thyrotropin (Thyroid-Stimulating Hormone [ TSH]) Receptor Antibodies |
|
|
240 | (1) |
|
Thyrotropin-Releasing Hormone (TRH) Stimulation Test |
|
|
240 | (1) |
|
|
240 | (1) |
|
Tissue Transglutaminase Antibody |
|
|
241 | (1) |
|
|
241 | (1) |
|
|
241 | (1) |
|
|
241 | (1) |
|
|
241 | (1) |
|
|
241 | (1) |
|
|
242 | (1) |
|
|
242 | (1) |
|
|
242 | (1) |
|
|
242 | (1) |
|
|
243 | (2) |
|
|
245 | (1) |
|
|
245 | (1) |
|
|
245 | (1) |
|
|
245 | (1) |
|
|
245 | (1) |
|
|
246 | (1) |
|
|
246 | (1) |
|
|
246 | (1) |
|
Urine Creatinine (24-Hour) |
|
|
246 | (1) |
|
|
246 | (1) |
|
|
246 | (1) |
|
Urine 5-Hydroxyindole-Acetic Acid (Urine 5-HIAA) |
|
|
246 | (1) |
|
Urine Glucose (Qualitative) |
|
|
246 | (1) |
|
|
246 | (1) |
|
|
247 | (1) |
|
|
247 | (1) |
|
Urine Ketones (Semiquantitative) |
|
|
247 | (1) |
|
|
247 | (1) |
|
|
247 | (1) |
|
|
247 | (1) |
|
|
247 | (1) |
|
|
247 | (1) |
|
|
248 | (1) |
|
|
248 | (1) |
|
|
248 | (1) |
|
Urine Protein (Quantitative) |
|
|
248 | (1) |
|
Urine Sodium (Quantitative) |
|
|
248 | (1) |
|
|
248 | (1) |
|
Urine Vanillylmandelic Acid (VMA) |
|
|
249 | (1) |
|
Varicella Zoster Virus (VZV) Serologic Testing |
|
|
249 | (1) |
|
Vasoactive Intestinal Peptide (VIP) |
|
|
249 | (1) |
|
Venereal Disease Research Laboratories (VDRL) |
|
|
249 | (1) |
|
|
250 | (1) |
|
|
250 | (1) |
|
|
250 | (1) |
|
Vitamin D, 1, 25 Dihydroxy Calciferol, Vitamin D 25(OH) D (25-Hydroxyvitamin D) |
|
|
251 | (1) |
|
|
251 | (1) |
|
|
252 | (1) |
|
|
252 | (1) |
|
|
252 | (1) |
|
|
252 | (1) |
|
Section III Diseases and Disorders |
|
|
253 | (236) |
|
|
257 | (232) |
|
|
259 | (2) |
|
2 Abdominal Aortic Aneurysm |
|
|
261 | (1) |
|
|
262 | (2) |
|
|
264 | (1) |
|
|
265 | (3) |
|
|
268 | (1) |
|
7 Addison Disease (Adrenal Insufficiency) |
|
|
269 | (1) |
|
|
270 | (2) |
|
|
272 | (2) |
|
10 Alkaline Phosphatase Elevation |
|
|
274 | (1) |
|
|
275 | (1) |
|
|
276 | (1) |
|
|
277 | (1) |
|
|
278 | (1) |
|
|
279 | (1) |
|
|
280 | (2) |
|
17 Antinuclear Antibody (ANA)-Positive |
|
|
282 | (2) |
|
|
284 | (2) |
|
|
286 | (1) |
|
|
287 | (3) |
|
|
290 | (1) |
|
22 Back Pain, Acute, Lumbosacral (LS) Area |
|
|
291 | (2) |
|
|
293 | (3) |
|
24 Bleeding Disorder, Congenital |
|
|
296 | (1) |
|
|
297 | (1) |
|
|
298 | (2) |
|
|
300 | (1) |
|
28 Cardiomegaly on Chest Radiograph |
|
|
301 | (1) |
|
|
302 | (3) |
|
|
305 | (2) |
|
|
307 | (2) |
|
|
309 | (1) |
|
|
310 | (2) |
|
34 Chronic Obstructive Pulmonary Disease |
|
|
312 | (1) |
|
|
313 | (1) |
|
36 Complex Regional Pain Syndrome (Reflex Sympathetic Dystrophy [ RSD]) |
|
|
314 | (1) |
|
|
315 | (1) |
|
38 Creatinine Phosphokinase (CPK) Elevation |
|
|
316 | (1) |
|
|
317 | (4) |
|
40 Deep Vein Thrombosis (DVT) |
|
|
321 | (2) |
|
|
323 | (1) |
|
|
324 | (1) |
|
|
325 | (3) |
|
44 Disseminated Intravascular Coagulation (DIC) |
|
|
328 | (1) |
|
|
329 | (1) |
|
|
330 | (1) |
|
|
331 | (1) |
|
|
332 | (1) |
|
|
333 | (2) |
|
50 Edema, Lower Extremity |
|
|
335 | (2) |
|
51 Endocarditis, Infective |
|
|
337 | (2) |
|
|
339 | (1) |
|
|
340 | (2) |
|
|
342 | (1) |
|
|
343 | (1) |
|
56 Fever of Undetermined Origin (FUO) |
|
|
344 | (1) |
|
|
345 | (2) |
|
58 Genital Lesions/Ulcers |
|
|
347 | (1) |
|
59 Granulomatosis With Polyangiitis (Wegener Granulomatosis) |
|
|
348 | (1) |
|
|
349 | (1) |
|
|
350 | (1) |
|
|
351 | (1) |
|
|
352 | (1) |
|
|
353 | (3) |
|
|
356 | (1) |
|
|
357 | (1) |
|
|
358 | (1) |
|
|
359 | (1) |
|
|
359 | (2) |
|
|
361 | (1) |
|
|
362 | (1) |
|
|
363 | (1) |
|
|
364 | (1) |
|
|
365 | (1) |
|
|
366 | (1) |
|
|
367 | (1) |
|
|
368 | (1) |
|
|
369 | (2) |
|
|
371 | (2) |
|
|
373 | (2) |
|
|
375 | (1) |
|
|
376 | (1) |
|
|
376 | (2) |
|
|
378 | (3) |
|
|
381 | (1) |
|
|
382 | (2) |
|
|
384 | (2) |
|
|
386 | (1) |
|
89 Liver Function Test Elevations |
|
|
387 | (2) |
|
|
389 | (1) |
|
91 Lymphadenopathy, Generalized |
|
|
390 | (2) |
|
92 Malabsorption, Suspected |
|
|
392 | (3) |
|
|
395 | (1) |
|
|
396 | (1) |
|
|
397 | (1) |
|
|
398 | (1) |
|
|
399 | (1) |
|
|
400 | (1) |
|
|
401 | (1) |
|
|
402 | (1) |
|
|
403 | (1) |
|
|
404 | (2) |
|
|
406 | (1) |
|
|
407 | (1) |
|
|
408 | (1) |
|
|
409 | (2) |
|
|
411 | (1) |
|
|
412 | (2) |
|
|
414 | (2) |
|
110 Parapharyngeal Abscess |
|
|
416 | (1) |
|
|
417 | (1) |
|
112 Pelvic Pain, Female Patient |
|
|
418 | (2) |
|
113 Peripheral Arterial Disease (PAD) |
|
|
420 | (2) |
|
|
422 | (1) |
|
|
423 | (2) |
|
|
425 | (2) |
|
|
427 | (1) |
|
|
428 | (1) |
|
119 Portal Vein Thrombosis |
|
|
429 | (2) |
|
|
431 | (2) |
|
|
433 | (1) |
|
122 Pruritus, Generalized |
|
|
434 | (2) |
|
|
436 | (2) |
|
124 Pulmonary Hypertension |
|
|
438 | (2) |
|
|
440 | (1) |
|
|
441 | (1) |
|
|
442 | (2) |
|
128 Renal Artery Stenosis |
|
|
444 | (3) |
|
|
447 | (1) |
|
130 Renal Tubular Acidosis |
|
|
448 | (2) |
|
|
450 | (1) |
|
|
451 | (1) |
|
|
452 | (1) |
|
134 Small-Bowel Obstruction |
|
|
453 | (2) |
|
135 Spinal Epidural Abscess |
|
|
455 | (1) |
|
|
456 | (2) |
|
|
458 | (2) |
|
138 Subarachnoid Hemorrhage |
|
|
460 | (1) |
|
139 Subclavian Steal Syndrome |
|
|
461 | (1) |
|
|
462 | (1) |
|
141 Superior Vena Cava Syndrome |
|
|
463 | (3) |
|
|
466 | (2) |
|
|
468 | (1) |
|
|
469 | (2) |
|
145 Thoracic Outlet Syndrome |
|
|
471 | (2) |
|
|
473 | (1) |
|
|
474 | (1) |
|
|
475 | (1) |
|
|
476 | (1) |
|
|
477 | (1) |
|
151 Transient Ischemic Attack (TIA) |
|
|
478 | (1) |
|
|
479 | (1) |
|
|
480 | (2) |
|
|
482 | (1) |
|
|
483 | (1) |
|
|
484 | (1) |
|
|
485 | (1) |
|
|
486 | (1) |
|
159 Weight Loss, Involuntary |
|
|
487 | (2) |
Appendix I General Guidelines for Ordering Computed Tomography |
|
489 | (2) |
Appendix II General Guidelines for Ordering Computed Tomography Angiography (CTA) |
|
491 | (2) |
Appendix III General Guidelines for Ordering Magnetic Resonance Imaging (MRI) |
|
493 | (2) |
Appendix IV The Electrocardiogram (ECG) |
|
495 | (12) |
Appendix V Pulmonary Function Testing |
|
507 | (10) |
Index |
|
517 | |